TABLE 7:

Comparison of Known-Group Validity (Discrimination of 28 Patients with AD from 28 Control Subjects) with Linear and Volumetric MR-Based Measures of MTL Atrophy in the MR Group

Control GroupAD GroupSensitivity (95% CI)*
Mean Crude Measure ± SD (mm)Mean Crude Measure ± SD (mm)Mean W-score ± SD
Radial width of the temporal horn (mm)
 Right3.7 ± 1.16.7 ± 2.03.0 ± 1.976% (56%–89%)
 Left3.3 ± 1.55.8 ± 2.51.7 ± 1.651% (32%–70%)
 Largest4.1 ± 1.27.2 ± 2.12.7 ± 1.773% (53%–87%)
Coronal width of the temporal horn (mm)
 Right3.0 ± 1.25.3 ± 2.32.4 ± 2.363% (43%–80%)
 Left3.2 ± 1.16.1 ± 2.33.4 ± 2.774% (54%–88%)
 Largest3.4 ± 1.26.5 ± 2.32.7 ± 2.169% (49%–84%)
Hippocampal volume (mm3)
 Right1951 ± 3351309 ± 3611.7 ± 1.252% (33%–71%)
 Left1797 ± 2881263 ± 3441.7 ± 1.052% (33%–71%)
 Smallest1774 ± 2821191 ± 3362.3 ± 1.271% (51%–86%)
  • Note.—P < .0005 for difference between groups on t test for all measures. W scores are age-standardized values, that is, the number of SD away from the age-specific atrophy value of control subjects (control W scores, 0 ± 1.0). Greater absolute values indicate greater atrophy.

  • * Values computed by modeling W scores of Patients with AD and control subjects with specificity set at 95%.